{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:46:53Z","timestamp":1785714413330,"version":"3.56.0"},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej19-0148","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T22:02:58Z","timestamp":1560808978000},"page":"827-835","source":"Crossref","is-referenced-by-count":7,"title":["An improved mouse model of Graves disease by once immunization with Ad-TSHR289"],"prefix":"10.1507","volume":"66","author":[{"given":"Yang","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouqiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"},{"name":"Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingtan","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"},{"name":"Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Diabetes, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital, Beijing 100053, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Burch HB, Cooper DS (2015) Management of Graves disease: a review. JAMA 314: 2544\u20132554.","DOI":"10.1001\/jama.2015.16535"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Holthoff HP, Li Z, Fassbender J, Reimann A, Adler K, et al. (2017) Cyclic peptides for effective treatment in a long-term model of Graves disease and orbitopathy in female mice. Endocrinology 158: 2376\u20132390.","DOI":"10.1210\/en.2016-1845"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Nagayama Y, Nakahara M, Abiru N (2015) Animal models of Graves\u2019 disease and Graves\u2019 orbitopathy. Curr Opin Endocrinol Diabetes Obes 22: 381\u2013386.","DOI":"10.1097\/MED.0000000000000186"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, et al. (2002) A novel murine model of graves\u2019 hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168: 2789\u20132794.","DOI":"10.4049\/jimmunol.168.6.2789"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Chen CR, Aliesky H, Pichurin PN, Nagayama Y, McLachlan SM, et al. (2004) Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves\u2019 disease as revealed by BALB\/c-C57BL\/6 hybrid mice. Endocrinology 145: 4927\u20134933.","DOI":"10.1210\/en.2004-0716"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wiesweg B, Johnson KT, Eckstein AK, Berchner-Pfannschmidt U (2013) Current insights into animal models of graves\u2019 disease and orbitopathy. Horm Metab Res 45: 549\u2013555.","DOI":"10.1055\/s-0033-1343451"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kaneda T, Honda A, Hakozaki A, Fuse T, Muto A, et al. (2007) An improved Graves\u2019 disease model established by using <i>in vivo<\/i> electroporation exhibited long-term immunity to hyperthyroidism in BALB\/c mice. Endocrinology 148: 2335\u20132344.","DOI":"10.1210\/en.2006-1077"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Zheng W, Wang R, Tan J, Li N, Meng Z (2017) An improved method for the establishment of a model of Graves\u2019 disease in BALB\/c mice. Mol Med Rep 15: 1471\u20131478.","DOI":"10.3892\/mmr.2017.6181"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Wu L, Xun L, Yang J, Xu L, Tian Z, et al. (2011) Induction of murine neonatal tolerance against Graves\u2019 disease using recombinant adenovirus expressing the TSH receptor A-subunit. Endocrinology 152: 1165\u20131171.","DOI":"10.1210\/en.2010-0737"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Yuan Q, Zhao Y, Zhu X, Liu X (2017) Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves\u2019 disease model. J Endocrinol Invest 40: 397\u2013407.","DOI":"10.1007\/s40618-016-0575-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, et al. (2003) The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111: 1897\u20131904.","DOI":"10.1172\/JCI200317069"},{"key":"12","unstructured":"12 Tang Y, Zhu X, Feng H, Fu S, Liu X (2019) Graves disease mouse model induced by recombinant adenovirus Ad-TSHR289. Shandong Medical 59: 49\u201352 (In Chinese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Chen CR, Pichurin P, Chazenbalk GD, Aliesky H, Nagayama Y, et al. (2004) Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves\u2019 disease. Endocrinology 145: 228\u2013233.","DOI":"10.1210\/en.2003-1134"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14 Kita-Furuyama M, Nagayama Y, Pichurin P, Mclachlan SM, Rapoport B, et al. (2003) Dendritic cells infected with adenovirus expressing the thyrotropin receptor induce Graves\u2019 hyperthyroidism in BALB\/c mice. Clin Exp Immunol 131: 234\u2013240.","DOI":"10.1046\/j.1365-2249.2003.02080.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ungerer M, Fassbender J, Li Z, Munch G, Holthoff HP (2017) Review of mouse models of Graves\u2019 disease and orbitopathy-novel treatment by induction of tolerance. Clin Rev Allergy Immunol 52: 182\u2013193.","DOI":"10.1007\/s12016-016-8562-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mizutori Y, Saitoh O, Eguchi K, Nagayama Y (2006) Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves\u2019 hyperthyroidism in mice. J Autoimmun 26: 32\u201336.","DOI":"10.1016\/j.jaut.2005.08.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Moshkelgosha S, So PW, Diaz-Cano S, Banga JP (2015) Preclinical models of Graves\u2019 disease and associated secondary complications. Curr Pharm Des 21: 2414\u20132421.","DOI":"10.2174\/1381612821666150316121945"},{"key":"18","unstructured":"18 Xia N, Ye X, Hu X, Song S, Xu H, et al. (2017) Simultaneous induction of Graves\u2019 hyperthyroidism and Graves\u2019 ophthalmopathy by TSHR genetic immunization in BALB\/c mice. PLoS One 12: e0174260."},{"key":"19","unstructured":"19 Wu LP, Shi BY, Xun LR, Guo LY, Yang J, et al. (2012) An exploration of induction methodology and experimental duration of Graves disease animal model. Zhonghua Nei Ke Za Zhi 51: 793\u2013797 (In Chinese)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Holthoff HP, Goebel S, Li Z, Fassbender J, Reimann A, et al. (2015) Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves\u2019 disease, tachycardia, and cardiac hypertrophy. Endocrinology 156: 1577\u20131589.","DOI":"10.1210\/en.2014-1813"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yuan X, Cheng G, Malek TR (2014) The importance of regulatory T-cell heterogeneity in maintaining self-tolerance. Immunol Rev 259: 103\u2013114.","DOI":"10.1111\/imr.12163"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 McLachlan SM, Rapoport B (2014) Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev 35: 59\u2013105.","DOI":"10.1210\/er.2013-1055"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Antonelli A, Ferrari SM, Corrado A, Domenicantonio AD, Fallahi P (2015) Autoimmune thyroid disorders. Autoimmun Rev 14: 174\u2013180.","DOI":"10.1016\/j.autrev.2014.10.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Ramos-Levi AM, Marazuela M (2016) Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr 63: 421\u2013429.","DOI":"10.1016\/j.endonu.2016.04.003"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Barrett K, Liakata E, Rao PV, Watson PF, Weetman AP, et al. (2004) Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor. Clin Exp Immunol 136: 413\u2013422.","DOI":"10.1111\/j.1365-2249.2004.02483.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/9\/66_EJ19-0148\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T03:54:42Z","timestamp":1569642882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/9\/66_EJ19-0148\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0148","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}